Clinical Trial: End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07791446) titled 'End Hole vs. Pressure-Modulated Delivery of Y-90 Resin Microspheres to Liver Metastases.' on Aug. 21.

Brief Summary: Patients with liver metastases undergoing planning arteriography for Y-90 administration by interventional radiology will be screened for study enrollment. If there are at least 2 planned delivery sites with the same target mean dose to tumor and at least 1 tumor in each angiosome that is measurable by RECIST criteria, the patient is potentially eligible for this study (see full inclusion and exclusion criteria). On the day of Y-90 administration, one delivery site will be randomized to a standard end hole microcathet...